Welcome to the CAR-T Resource Library

CAR-T (Chimeric Antigen Receptor-T cell) therapy is a new and exciting cellular immunotherapy with the potential to treat many cancers including chronic lymphocytic leukemia (CLL) and lymphomas.

It is the first FDA approved genetic therapy, the first “living drug” and involves removing and modifying a patient’s own white blood cells, then returning them to the patient’s body to fight their specific cancer.

Be sure to visit Dr. Brian Koffman’s CAR-T Blog!

The CAR-T Blog

CAR-T Tribune Resource Page

CAR-T is already approved in other blood cancers and more trials are ongoing to expand how it might help patients....

My Boston Marathon

By Michele Palmer- Patient The morning of the 2018 Boston Marathon started ominously: gusty winds, drenching rain, and temperatures in the...

CAR-T: Targets and Limitations

All our MRD educational efforts are directed at the non-medical reader, but they also endeavor to be a true reflection...